Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-small-cell lung cancer?

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 3, 2011, Pages 642-646

  Fontaine, Eustace ^a   McShane, James ^a   Carr, Martyn ^a   Shackcloth, Michael ^a   Mediratta, Neeraj ^a   Page, Richard ^a   Poullis, Michael ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Lung cancer; PET; Survival

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; KIDNEY DISEASE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SURVIVAL TIME;

AGED; BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 80051569629     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.12.053     Document Type: Article

References (9)

1. Lim E., Baldwin D., Beckles M., Duffy J., Entwisle J., Faivre-Finn C., Kerr K., Macfie A., McGuigan J., Padley S., Popat S., Screaton N., Snee M., Waller D., Warburton C., Win T. Guidelines on the radical management of patients with lung cancer. Thorax (Supplement) 2010, 65:iii1-iii27. British Thoracic Society and the Society for Cardiothoracic Surgery in Great Britain and Ireland.
2. Maziak D.E., Darling G.E., Inculet R.I., Gulenchyn K.Y., Driedger A.A., Ung Y.C., Miller J.D., Gu C.S., Cline K.J., Evans W.K., Levine M.N. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009, 151(4):221-228.
3. Fischer B., Lassen U., Mortensen J., Larsen S., Loft A., Bertelsen A., Ravn J., Clementsen P., Høgholm A., Larsen K., Rasmussen T., Keiding S., Dirksen A., Gerke O., Skov B., Steffensen I., Hansen H., Vilmann P., Jacobsen G., Backer V., Maltbaek N., Pedersen J., Madsen H., Nielsen H., Højgaard L. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009, 361:32-39.
4. Fontaine E., McShane J., Page R., Shackcloth M., Mediratta N., Carr M., Soorae A., Poullis M. Aspirin and non-small cell lung cancer resections: effect on long-term survival. Eur J Cardiothorac Surg 2010, 38(1):21-26.
5. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2(8):706-714. International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions.
6. Groome P.A., Bolejack V., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., Goldstraw P. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2(8):694-705. IASLC International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions.
7. Chansky K., Sculier J.P., Crowley J.J., Giroux D., Van Meerbeeck J., Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009, 4(7):792-801. International Staging Committee and Participating Institutions.
8. Al-Sarraf N., Gately K., Lucey J., Aziz R., Doddakula K., Wilson L., McGovern E., Young V. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg 2008, 34(4):892-897.
9. Scheuermann J.S., Saffer J.R., Karp J.S., Levering A.M., Siegel B.A. Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience. J Nucl Med 2009, 50(7):1187-1193.